Cypher Select

DEVICE3 trials

Conditions

Coronary ArteriosclerosisCoronary Artery DiseaseCoronary Artery RestenosisCoronary Artery StenosisIschemic Heart DiseaseMyocardial IschemiaStent ThrombosisTotal Coronary Occlusion

Phase 2

The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.

CompletedNCT00232791

Cordis US Corp.Coronary Artery Disease

Start: 2004-01-31End: 2005-03-31Updated: 2008-08-06

Phase 3

Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients

CompletedNCT00660478

Evald Hoej ChristiansenIschemic Heart Disease

Start: 2006-01-31End: 2009-10-31Updated: 2013-08-29

Phase 4

XIENCE V: SPIRIT WOMEN Sub-study

CompletedNCT01182428

Abbott Medical DevicesCoronary Arteriosclerosis, Coronary Artery Disease, Coronary Artery Restenosis +5

Start: 2008-09-30End: 2011-07-31Updated: 2012-08-07

Related Papers

A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study

PLoS ONE2017-08-1016 citations

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

2014-03-1482 citations

3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.

2012-08-0129 citations

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.

2010-03-16147 citations